A recent study published in the journal Addiction has found that vaping CBD does not significantly affect driving performance. The clinical trial, conducted by a team of Spanish researchers, assessed participants' simulated driving abilities after inhaling either CBD or a placebo.
The study's findings showed no statistically significant changes in the subjects' overall driving performance scores after vaporizing products containing 15% or 30% CBD. Additionally, the researchers observed no significant differences in secondary outcomes, such as lane positioning, reaction time, or collisions. The study also found that CBD administration had little impact on the subjects' visual functions.
The authors concluded that vaporized CBD appears to be a safe substance for vision-dependent tasks like driving, based on the results of this study. However, they noted that further research is needed to determine if higher doses of CBD could pose any risks.
These findings align with a 2022 Swiss study that reported no changes in simulated driving performance after the oral administration of up to 1500 mg of CBD. Another study also found that inhaling high-CBD, low-THC botanical cannabis did not impair driving abilities.
As the use of CBD products continues to grow, these studies provide valuable insights into the safety of CBD consumption in relation to driving and vision-dependent tasks. While more research is needed to fully understand the effects of CBD at various doses and delivery methods, these initial findings suggest that CBD vaping may be a safe option for those who need to drive or perform other visually demanding activities.
